Thinly traded micro cap Enzo Biochem (NYSE:ENZ) jumps 64% premarket on increased volume in reaction to its announcement that it will begin accepting respiratory specimens next week for its in-house test for COVID-19.
The company says it is consulting with the CDC on
the implementation of enhanced offerings such as virus-inactivating
specimen collection media to lessen transmission risks for healthcare
providers and clinical laboratory personnel, the development of more
relevant positive controls and improved sensitivity.
https://seekingalpha.com/news/3549373-enzo-biochem-up-64-premarket-on-launch-of-coronavirus-testing-service
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.